FDA Inspection
Regional Women's Health Group, LLCFDA Inspection 1096100 - Regional Women's Health Group, LLC - July 12, 2019
Record Details
This FDA Inspection record concerns Regional Women's Health Group, LLC, with an inspection on July 12, 2019, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Inspection Date
- July 12, 2019
- Product Type
- Biologics
View Company Profile
ID · abecb8c8-9910-4843-8c24-594a7983929d
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1096100
- FDA center
- Biologics
- Project area
- Blood and Blood Products
FDA Citations
2- 21 CFR 1271.75(a)(1)Risk factors, clinical evidence
- 21 CFR 1271.85(a)Infection with communicable disease agents
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Regional Women's Health Group, LLC
5| Date | Classification | Office | Project area |
|---|---|---|---|
| April 29, 2024 | VAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| April 22, 2022 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| November 19, 2014 | VAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| July 11, 2013 | VAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| March 4, 2011 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
Other documents for Regional Women's Health Group, LLC
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.